Elissa G. Currie, Olga Rojas, Isaac S. Lee, Khashayar Khaleghi, Alberto Martin, Jen Gommerman, Scott Gray-Owen
{"title":"Protection against Neisseria meningitidis nasopharyngeal colonization relies on antibody opsonization and phagocytosis by neutrophils","authors":"Elissa G. Currie, Olga Rojas, Isaac S. Lee, Khashayar Khaleghi, Alberto Martin, Jen Gommerman, Scott Gray-Owen","doi":"10.1101/2024.09.11.612551","DOIUrl":null,"url":null,"abstract":"Neisseria meningitidis is a human-restricted pathogen that can cause a rapidly progressing invasive meningococcal disease, yet it is also a regular inhabitant of the human nasopharynx. Vaccines that target N. meningitidis aim to prevent invasive disease, but their ability to interfere with nasal colonization could effectively eradicate this bacteria in a population, and so is an important target for meningococcal vaccine design. While protection against invasive meningococcal disease is classically attributed to IgG-dependent complement activation and bacterial killing, there remains no indication of what confers protection against nasopharyngeal colonization, making it impossible to deliberately target this stage during vaccine development. Moreover, without understanding what confers protection in this tissue site, it is impossible to understand the level of susceptibility within a population. To address this, we have taken advantage of the CEACAM1-humanized mouse model to characterize immune effectors that protect against nasal carriage of N. meningitidis. Protection against nasal colonization could be induced by live mucosal infection or by parenteral immunization with heat-killed bacteria. Mice possessing genetic deficiencies in B cells were used to evaluate the role of B cells and a specific antibody response, while neutrophil and complement depletion were used to evaluate their respective contributions to immunization-induced protection against meningococcal nasal carriage. Despite the essential role for complement killing in preventing invasive meningococcal disease, complement was not required for protection against nasal colonization. Instead, N. meningitidis-specific antibodies and neutrophils were both required to protect mice against the nasal infection. Combined, these data suggest that phagocytic bacterial killing is necessary for protection against mucosal colonization by N. meningitidis, indicating that nasal immunoglobulin with the ability to promote opsonophagocytosis must be considered as a correlate of protection against meningococcal carriage.","PeriodicalId":501357,"journal":{"name":"bioRxiv - Microbiology","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"bioRxiv - Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.09.11.612551","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Neisseria meningitidis is a human-restricted pathogen that can cause a rapidly progressing invasive meningococcal disease, yet it is also a regular inhabitant of the human nasopharynx. Vaccines that target N. meningitidis aim to prevent invasive disease, but their ability to interfere with nasal colonization could effectively eradicate this bacteria in a population, and so is an important target for meningococcal vaccine design. While protection against invasive meningococcal disease is classically attributed to IgG-dependent complement activation and bacterial killing, there remains no indication of what confers protection against nasopharyngeal colonization, making it impossible to deliberately target this stage during vaccine development. Moreover, without understanding what confers protection in this tissue site, it is impossible to understand the level of susceptibility within a population. To address this, we have taken advantage of the CEACAM1-humanized mouse model to characterize immune effectors that protect against nasal carriage of N. meningitidis. Protection against nasal colonization could be induced by live mucosal infection or by parenteral immunization with heat-killed bacteria. Mice possessing genetic deficiencies in B cells were used to evaluate the role of B cells and a specific antibody response, while neutrophil and complement depletion were used to evaluate their respective contributions to immunization-induced protection against meningococcal nasal carriage. Despite the essential role for complement killing in preventing invasive meningococcal disease, complement was not required for protection against nasal colonization. Instead, N. meningitidis-specific antibodies and neutrophils were both required to protect mice against the nasal infection. Combined, these data suggest that phagocytic bacterial killing is necessary for protection against mucosal colonization by N. meningitidis, indicating that nasal immunoglobulin with the ability to promote opsonophagocytosis must be considered as a correlate of protection against meningococcal carriage.
脑膜炎奈瑟菌是一种人类限制性病原体,可引起进展迅速的侵袭性脑膜炎球菌疾病,但它也是人类鼻咽部的常住菌。针对脑膜炎球菌的疫苗旨在预防侵袭性疾病,但其干扰鼻腔定植的能力可有效消灭人群中的这种细菌,因此是脑膜炎球菌疫苗设计的一个重要目标。虽然对侵袭性脑膜炎球菌疾病的保护作用通常归因于依赖 IgG 的补体激活和细菌杀灭,但目前仍没有迹象表明是什么赋予了对鼻咽定植的保护作用,因此在疫苗开发过程中不可能刻意针对这一阶段。此外,如果不了解是什么在这一组织部位产生保护作用,就不可能了解人群的易感性水平。为了解决这个问题,我们利用 CEACAM1 人源化小鼠模型来描述保护鼻腔不被脑膜炎奈瑟菌携带的免疫效应因子。鼻腔定植的保护可通过活体粘膜感染或用热杀死的细菌进行肠外免疫诱导。利用遗传性 B 细胞缺陷的小鼠来评估 B 细胞和特异性抗体反应的作用,同时利用中性粒细胞和补体耗竭来评估它们各自对免疫诱导的脑膜炎球菌鼻腔携带保护作用的贡献。尽管补体杀伤在预防侵袭性脑膜炎球菌疾病中发挥着重要作用,但鼻腔定植却不需要补体来提供保护。相反,脑膜炎球菌特异性抗体和中性粒细胞都是保护小鼠免受鼻腔感染的必要条件。这些数据综合起来表明,要防止脑膜炎球菌在粘膜上定植,必须要有吞噬细菌的能力,这表明必须将具有促进嗜蛋白吞噬能力的鼻腔免疫球蛋白视为防止脑膜炎球菌携带的相关因素。